Research progress on nanotechnology of traditional Chinese medicine to enhance the therapeutic effect of osteoarthritis
Drug Delivery and Translational Research · 2024
DOI: 10.1007/s13346-024-01517-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Delivery and Translational Research, 2024. Verfasst von Yue Peng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed By the Province and Minis…. Hauptthemen laut MEDLINE: Osteoarthritis, Medicine, Chinese Traditional, Antioxidants, Nanotechnology. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 155 Literaturangaben. Gefördert von: The National Nature Science Foundation of China, Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China.
Abstract (Originalsprache)
Osteoarthritis (OA) is a prevalent chronic condition that primarily impacts the articular cartilage and surrounding bone tissue, resulting in joint inflammation and structural deterioration. The etiology of OA is multifaceted and intricately linked to the oxidative stress response of joint tissue. Oxidative stress (OS) in OA leads to the creation of reactive oxygen species (ROS) and other oxidizing agents, resulting in detrimental effects on chondrocytes. This oxidative damage diminishes the flexibility and robustness of cartilage, thereby expediting the progression of joint deterioration. Therefore, the antioxidant effect is crucial in the treatment of OA. Currently, a considerable number of components found in traditional Chinese medicine (TCM) have been scientifically demonstrated to exhibit remarkable antioxidant and anti-inflammatory properties. Nevertheless, the utilization of this program is considerably constrained as a result of intrinsic deficiencies, notably stability concerns. The successful amalgamation of TCM components with nanotechnology has properly tackled these concerns and enhanced the efficacy of therapeutic results. The objective of this study is to delineate the antioxidant characteristics of nano-TCM and assess the current inventory of literature pertaining to the application of nano-TCM in the treatment of OA. In conclusion, this paper will now turn to the constraints and potential avenues for the advancement of nano-TCM within the realm of OA therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed By the Province and Ministry, Guangxi Key Laboratory of Regenerative Medicine & Key Laboratory…
- Guangxi Colleges and Universities Key Laboratory of Biological Molecular Medicine Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangxi Medical University, Shuangyong Road…
- Laboratory of Basic Medicine Center, Guangxi Medical University, Shuangyong Road, 530021, Nanning, Guangxi, People's Republic of China. 15778027991@163.com.
ORCID-Profile: Sijia Liu
Förderung
- The National Nature Science Foundation of China
- Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China
Zitieren
APA
Peng, Y., Yang, Z., Li, J., & Liu, S. (2024). Research progress on nanotechnology of traditional Chinese medicine to enhance the therapeutic effect of osteoarthritis. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01517-w
Vancouver
Peng Y, Yang Z, Li J, Liu S. Research progress on nanotechnology of traditional Chinese medicine to enhance the therapeutic effect of osteoarthritis. Drug Delivery and Translational Research. 2024. doi:10.1007/s13346-024-01517-w
BibTeX
@article{Peng2024,
author = {Peng, Yue and Yang, Zhengshuang and Li, Jinling and Liu, Sijia},
title = {Research progress on nanotechnology of traditional Chinese medicine to enhance the therapeutic effect of osteoarthritis},
journal = {Drug Delivery and Translational Research},
year = {2024},
doi = {10.1007/s13346-024-01517-w}
}
EUVIMED